Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer.

J Clin Med · 2022 · PMC8911022 · PMID 35268305

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

only marginally significantno p-value reported

Regarding the time to progression of the disease, the estimates were also very stable, showing in fully adjusted models the tendency to a higher risk of outcome for patients with a PLT count greater than 400 × 103/μL, however, with only marginally significant results (HR = 1.64, 95% CI: 0.99–2.73 or HR = 1.64, 95% CI: 0.98–2.76).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.